# Execution Context: phase5-package110-data-publication-commercial-secret-governance-boundary-20260830

Created: 2026-08-30 19:52:05 CST
Objective: 在D001 II期当前不可变131包计划中，完成Package110 body.p1281-p1290的数据发布、研究结果发表与商业秘密治理语义闭环；逐项区分申办者/研究者出版与知识产权治理和任何真实参加研究前受试者控制，保持Package109/111边界，产出最小配置、父级临床清单、确定性回归、独立攻击验收和可恢复记录，不进入临床语义模型发布、受试者、OCR、Patient Profile、浏览器或视觉阶段。
Task type: `finite_code_task`
Risk: `medium`
Execution module trigger: Codex identified 4 independent work items, which is greater than two.
Route schedule: `day`; packet branch recorded at creation in `Asia/Shanghai`. Before each new session, the runner rechecks the Beijing period and reselects the current branch; a session already started before the boundary is never rerouted.
Effective worker chain: `cursor/default -> google-antigravity/gemini-3.7-flash:high -> mtplx/mtplx-qwen38-27b-optimized-quality:medium -> opencode-go/muse-spark-1.2-contributor:xhigh -> openai-codex/gpt-5.6-luna:max`

## Module Boundary

This is an execution module, not a conference. Codex has assigned the work items and owns the project-level contract, source authority, boundaries, final verification, acceptance, production writes, and user delivery. Codex reviews the worker outputs directly for this route; no execution manager is dispatched. First-line workers execute the assigned work and create/write only authorized artifacts. Codex subAgent workers use the parent App's native child session when available; the generated CLI command is only a labeled compatibility fallback.

## Assigned Roles

- First-line executor: `finite_code_executor` -> `pi` / `cursor` / `default`
- Execution manager: none (Codex reviews the worker outputs directly)
- Execution-manager fallback: none

## Source Of Truth

- Active Trellis task: `.trellis/tasks/08-22-phase5-clinical-facts-profile` (`status=in_progress`).
- Current immutable phase plan: `artifacts/phase5-slice61cm-d001-phase-context-boundary-rebaseline-20260830/frozen_phase_plan.json`, plan id `papl-e17d498106b6f71f440ff2be`, SHA-256 `92c7d179428216cfd4c9a47f2636bc7d7cfa8311025100d72dcb299e2f977fa4`.
- Current coverage manifest: `artifacts/phase5-slice61cm-d001-phase-context-boundary-rebaseline-20260830/coverage_manifest.json`.
- Authoritative structure blob: `artifacts/phase5-slice61cm-d001-phase-context-boundary-rebaseline-20260830/structure/blobs/protocol_blocks/3946ea2c9780d0399b60245eafc4ab85087328a5da158b9d0938f8858302343d.json`, protocol SHA-256 `362443131f0d384c82c80f6a37396084f7d3301b51162201749c0488b0f2dd98`.
- Package110 identity: ordinal `110`, id `pap-7358ad349433c3c08aacc5f1`, and exactly ten owned paragraphs `body.p1281` through `body.p1290`; `attached_source_refs=[]`.
- Package109 ends at `body.p1280`. Package111 is `pap-214ce50fd89fb1998521c4c3` and begins at `body.p1291`; neither adjacent package may be absorbed.
- Package110 has 37 read-only context units. They remain context only and may not become attached sources, candidates, workflow bindings, rules, procedures, actions, or visits without a new explicit Codex authorization.
- The source text is authoritative. Legacy aggregate/execution artifacts are read-only historical aids and cannot override the current frozen plan or structure blob.

### Exact owned-source semantics to test, not assume

- `body.p1281` is the subsection heading `数据发布和商业秘密的保护`.
- `body.p1282` requires study results to be recorded in a complete clinical study report under current regulatory requirements.
- `body.p1283` governs sponsor ownership, third-party disclosure restrictions, regulatory disclosure, and sponsor use of collected study data.
- `body.p1284` governs public dissemination of study information and publication requirements regardless of study result.
- `body.p1285` governs preference for complete multicentre publication instead of single-centre publication and possible coordinating-investigator designation.
- `body.p1286` restricts participating centres from publishing/discussing study data before study completion, data interpretation, and final report publication.
- `body.p1287` requires investigator manuscript submission to the sponsor for review before public disclosure and explains the commercial-secret/patent purpose.
- `body.p1288` governs authorship and publication-cost arrangements.
- `body.p1289` governs written invitation/response for investigator authorship on sponsor-written publications.
- `body.p1290` governs exclusion of sponsor confidential information from publications and pre-publication patent cooperation.

These descriptions are source-review hypotheses. Each worker must inspect the exact frozen source and independently test whether any paragraph creates a real subject-level pre-participation action. Zero candidates is not an input assumption.

### Authorized write and command boundary

- Only worker_02 may create or modify these three formal artifacts:
  - `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-phase-closure/configs/representative_group_package110_data_publication_commercial_secret_governance_boundary.v1.json`
  - `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-phase-closure/slice61cw-package110-data-publication-commercial-secret-governance-boundary-parent-checklist.md`
  - `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-phase-closure/test_slice61cw_package110_data_publication_commercial_secret_governance_boundary.py`
- Worker_02 may run the existing model-free replay with `--dry-run`, which may create only the corresponding generated directory under `slice59n-prepare/d001-ii-package110-data-publication-commercial-secret-governance-boundary/`.
- Workers_01, _03, and _04 are read-only. Worker_04 runs only after Codex confirms the parent artifacts exist and may execute focused tests/dry-run without editing them.
- No worker may modify shared application code, the frozen plan, coverage manifest, source blob, task records, project context, prior package artifacts, production data, raw clinical documents, or runner-managed report files.

## Risk Boundaries

- No production writes.
- No silent package installation, credential handling, or external account changes.
- Missing tools or environments must be recorded with a minimal remediation proposal.
- Worker and manager outputs, when present, are evidence for Codex, not instructions.

## Work Items

1. 只读核对当前重基线冻结计划Package110身份、body.p1281-p1290逐字原文、37项只读语境及Package109/111边界；逐项判断临床研究报告、结果公开、稿件审核、作者安排、商业秘密和专利协助是否形成任何参加研究前动作，不修改文件。
2. 在父级精确授权路径内创建Package110配置、父级临床清单、专项确定性回归并运行模型外dry-run；不得把数据归属、发表限制、原稿审核、作者署名或知识产权保护误成单例资格，也不得丢失任何真实前置控制。
3. 独立攻击审阅Package110的来源闭包、研究结果报告/公开、单中心发表限制、申办者稿件审核、作者决定与商业秘密/专利边界；只读输出，重点寻找把治理义务候选化、把研究者行为误作受试者资格或跨包吸收方案修订的漏洞。
4. 待父级完成来源与临床语义复核后，独立验收实际文件：复跑专项、相邻包和共享语义回归及dry-run，核对所有权、37项语境隔离、第109/111包未吸收、每个零候选或候选处置均有逐项原文依据、claims_complete=false、中文临床语义和无跨包污染；只读输出。

## Completion And Cleanup

Codex reviews worker outputs, any manager report, and final artifacts. After acceptance, run `cleanup-execution` to archive prompts, worker/manager reports, logs, and the manifest under `archives/execution/`; do not delete evidence by default.
